Mitchell SM et al. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer Genes 2016, 7(12), 125; doi:10.3390/genes7120125
Young, G. P., Pedersen, S. K., Mansfield, S., Murray, D. H., Baker, R. T., Rabbitt, P., Byrne, S., Bambacas, L., Hollington, P. and Symonds, E. L. (2016), A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer. Cancer Med. doi:10.1002/cam4.868
Pedersen et al. A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer. PLoS One 2015;10(4):e0125041.
Symonds EL et al. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia. Clin Trans Gastro. 2016; 7, e137.
Pedersen et al. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC CANCER 15(1):654. October 2015.
Mitchell SM et al. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer. 2014;14:54.
Pedersen SK et al. CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia. Epigenetics. 2014 Aug;9(8):1071-82.
Collins MG et al. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy. BMJ. 2012 Jul 25;345:e4657.
LaPointe LC et al. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. PLoS One. 2012;7(1):e29059.
Graham LD et al. Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas. Genes Cancer. 2011 Aug;2(8):829-40.
LaPointe LC et al. Map of differential transcript expression in the normal human large intestine. Physiol Genomics. 2008 Mar 14;33(1):50-64.
Smith A et al. Comparison of of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006 Nov 1;107(9):2152-9.
Young GP et al. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J Med Screen. 2003;10(3):123-8.
Cole SR et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003;10(3):117-22.